Risks of specific congenital anomalies in offspring of women with diabetes: A systematic review and meta-analysis of population-based studies including over 80 million births

Abstract

Background Pre-gestational diabetes mellitus (PGDM) has been known to be a risk factor for congenital heart defects (CHDs) for decades. However, the associations between maternal PGDM and gestational diabetes mellitus (GDM) and the risk of specific types of CHDs and congenital anomalies (CAs) in other systems remain under debate. We aimed to investigate type-specific CAs in offspring of women with diabetes and to examine the extent to which types of maternal diabetes are associated with increased risk of CAs in offspring. Methods and findings We searched PubMed and Embase from database inception to 15 October 2021 for population-based studies reporting on type-specific CAs in offspring born to women with PGDM (combined type 1 and 2) or GDM, with no limitation on language. Reviewers extracted data for relevant outcomes and performed random effects meta-analyses, subgroup analyses, and multivariable meta-regression. Risk of bias appraisal was performed using the Cochrane Risk of Bias Tool. This study was registered in PROSPERO (CRD42021229217). Primary outcomes were overall CAs and CHDs. Secondary outcomes were type-specific CAs. Overall, 59 population-based studies published from 1990 to 2021 with 80,437,056 participants met the inclusion criteria. Of the participants, 2,407,862 (3.0%) women had PGDM and 2,353,205 (2.9%) women had GDM. The meta-analyses showed increased risks of overall CAs/CHDs in offspring born to women with PGDM (for overall CAs, relative risk [RR] = 1.99, 95% CI 1.82 to 2.17, P < 0.001; for CHDs, RR = 3.46, 95% CI 2.77 to 4.32, P < 0.001) or GDM (for overall CAs, RR = 1.18, 95% CI 1.13 to 1.23, P < 0.001; for CHDs, RR = 1.50, 95% CI 1.38 to 1.64, P < 0.001). The results of the meta-regression analyses showed significant differences in RRs of CAs/CHDs in PGDM versus GDM (all P < 0.001). Of the 23 CA categories, excluding CHD-related categories, in offspring, maternal PGDM was associated with a significantly increased risk of CAs in 21 categories; the corresponding RRs ranged from 1.57 (for hypospadias, 95% CI 1.22 to 2.02) to 18.18 (for holoprosencephaly, 95% CI 4.03 to 82.06). Maternal GDM was associated with a small but significant increase in the risk of CAs in 9 categories; the corresponding RRs ranged from 1.14 (for limb reduction, 95% CI 1.06 to 1.23) to 5.70 (for heterotaxia, 95% CI 1.09 to 29.92). The main limitation of our analysis is that some high significant heterogeneity still persisted in both subgroup and sensitivity analyses. Conclusions In this study, we observed an increased rate of CAs in offspring of women with diabetes and noted the differences for PGDM versus GDM. The RRs of overall CAs and CHDs in offspring of women with PGDM were higher than those in offspring of women with GDM. Screening for diabetes in pregnant women may enable better glycemic control, and may enable identification of offspring at risk for CAs.

Epigenetic implications in maternal diabetes and metabolic syndrome‐associated risk of orofacial clefts

“…Infants born to mothers with either GDM or PGDM have higher risks of having congenital anomalies, most frequently involving cardiovascular defects (Aberg et al, 2001;Moore et al, 2000;Spilson et al, 2001). A recent meta-analysis of population-based studies confirmed that the relative risks (RRs) of overall congenital anomalies in offspring of women with PGDM were higher than those in offspring of women with GDM (Zhang et al, 2022).…”

The birth of cardiac disease: Mechanisms linking gestational diabetes mellitus and early onset of cardiovascular disease in offspring

“…GDM impairs cardiogenesis (Chaudhari et al, 2008; Dervisoglu et al, 2018), having a deleterious effect. It was estimated, through the available research, that infants born to mothers portraying GDM who needed insulin during the third trimester of pregnancy are around 20 times more likely to develop major anomalies regarding the cardiovascular system (i.e., malformations) than those born to non‐GDM mothers, with an absolute risk for infants from diabetic mothers around 9.7% (Becerra et al, 1990; Zhang et al, 2022, PMID: 35104296). Insulin‐binding cell receptors control fetal cardiac development and growth, being more abundant in the interventricular septum (Dervisoglu et al, 2018), regulating substrates needed for myocardial growth, therefore playing an essential role in physiological hypertrophy (Dale Abel, 2021).…”

Prenatal exposure to pesticide mixture in Argentina: A pilot study in puerperal women from Santa Fe province

“…Chronic noncommunicable diseases (CND), like maternal arterial hypertension, diabetes mellitus (DM), and thyroids disease, could affect neonatal development (Ibrahim et al, 2022; Ogilvy‐Stuart & James, 2022; Ramakrishnan et al, 2015; Zhang et al, 2022). Acute infections of the TORCH complex (Toxoplasmosis, Rubella, Cytomegalovirus, and Herpes simplex virus) during pregnancy are related to congenital disorders, such as craniofacial, cardiopathies, and neural tube disease (NTD; Nayak et al, 2022).…”